Caplin Steriles Receives USFDA Approval for Levetiracetam in Sodium Chloride Injection for Epilepsy Treatment in Infusion Bags

Caplin Steriles Limited has received approval from the United States Food and Drug Administration (USFDA) for its Levetiracetam in Sodium Chloride Injection, designed for use in infusion bags. The approval covers the 500 mg/100 mL, 1000 mg/100 mL, and 1500 mg/100 mL presentations. Levetiracetam is widely used in the treatment of epilepsy to control seizures. This milestone highlights Caplin Steriles’ growing portfolio of complex injectable products for the U.S. market. The company’s continued focus on innovation and regulatory compliance strengthens its position as a reliable partner in the pharmaceutical industry.

Source: Company announcement and regulatory filings.

STORIES YOU MAY LIKE

Mega Milestone: 8,000 Projects Completed, Indian Cities Shine Brighter

Akshaya Tritiya Bonanza: Retailers Sweeten the Pot as Gold Prices Touch the Sky

Legends on Board: Malaysia Airlines Debuts Manchester United Livery in Grand Style